NCT05296941

Brief Summary

Cancer is a complex disease; its different causes and types have a strong impact on patient treatment and prognosis. To improve understanding of the disease, its causes and progression, the investigators will develop a simple, cost-effective system for continuous control of mucosal lesions with non-invasive brush biopsy that can be managed in primary dental care, as an alternative to tissue biopsy in order to reduce the number of oral cavity cancers.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
44mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Aug 2023Dec 2029

First Submitted

Initial submission to the registry

March 8, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 25, 2022

Completed
1.4 years until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

September 8, 2023

Status Verified

September 1, 2023

Enrollment Period

6.4 years

First QC Date

March 8, 2022

Last Update Submit

September 6, 2023

Conditions

Keywords

oral cancerpotentially malignant disordersleukoplakiaerythroplakiaoral lichen planus

Outcome Measures

Primary Outcomes (1)

  • Numbers of cancers diagnosed by brush sampling

    5 years

Study Arms (2)

Brush biopsy

EXPERIMENTAL

Brusch biopsy at baseline and at 3 or 6 months

Procedure: Brush sampling

Care as usual

ACTIVE COMPARATOR

Control at 3 or 6 month, surgical biopsy when needed

Procedure: Brush sampling

Interventions

Brush sampling instead of surgical biopsy for control of reaccurance

Brush biopsyCare as usual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persons 18 years of age or older who have the clinical diagnosis of leukoplakia, erythroplakia or proliferative verrukös leukoplakia

You may not qualify if:

  • People who cannot read and understand information in Swedish.
  • Ongoing chemotherapy and/or radiotherapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kristina Edman

Falun, Dalarna County, 79129, Sweden

RECRUITING

MeSH Terms

Conditions

Mouth NeoplasmsLeukoplakiaErythroplasiaLichen Planus, Oral

Condition Hierarchy (Ancestors)

Head and Neck NeoplasmsNeoplasms by SiteNeoplasmsMouth DiseasesStomatognathic DiseasesPrecancerous ConditionsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsLichen PlanusLichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Public dental care

    Uppsala University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jan-Michael Hirsch

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

March 8, 2022

First Posted

March 25, 2022

Study Start

August 1, 2023

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2029

Last Updated

September 8, 2023

Record last verified: 2023-09

Locations